To put all eggs in one basket is stupidity in the best of times in relation to shares... But to do it with a small biotech stock really boggles the mind... Plenty of trials to come over the next few years, only needs for one trial not to work, and the product isn't approved, then PRR is back at 1c or less...
Have a look at PXS on what can happen... I don't think PRR has a backup plan if their product doesn't get approved, only invest what you can afford to lose and diversify, putting all eggs in one basket is ludicrous, especially in a biotech stock...
Best of luck to you
i bet the farm on it!, page-5
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.015(4.48%) |
Mkt cap ! $464.8M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.8¢ | 31.5¢ | $1.587M | 4.950M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 35998 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 286931 | 7 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |